Application for quotation of +securities
Update Summary
For personal use only
Entity name
LIVING CELL TECHNOLOGIES LIMITED
Announcement Type
Update to previous announcement
Date of this announcement
Wednesday December 29, 2021
Reason for the update
Correction to number of Free Attaching Options issued from 15,052,679 to 15,052,678.
Refer to next page for full details of the announcement
Application for quotation of +securities | 1 / 6 |
Application for quotation of +securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
LIVING CELL TECHNOLOGIES LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 | Registered number type | Registration number |
ACN | 104028042 | |
1.3 | ASX issuer code | |
LCT |
1.4 The announcement is
Update/amendment to previous announcement
1.4a Reason for update to a previous announcement
Correction to number of Free Attaching Options issued from 15,052,679 to 15,052,678.
1.4b Date of previous announcement to this update
29/12/2021
1.5 Date of this announcement
29/12/2021
Application for quotation of +securities | 2 / 6 |
Application for quotation of +securities
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
For personal use only
Previous Appendix 3B details: | ||
Announcement Date and | Announcement Title | Selected Appendix 3B to submit quotation |
Time | request | |
09-Dec-2021 17:22 | Update - Update - Proposed issue of | |
A standard +pro rata issue (renounceable) | ||
securities - LCT | ||
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
No
Application for quotation of +securities | 3 / 6 |
Application for quotation of +securities
Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
Corporate Action Component Detail | ||||
only | ASX +security code and description | |||
LCT : ORDINARY FULLY PAID | ||||
Issue date | ||||
use | 30/12/2021 | |||
I ue details | ||||
personal | Number of +securities to be quoted | |||
45,158,037 | ||||
Issue currency | Issue price or consideration per +security | |||
AUD - Australian Dollar | AUD 0.00800000 | |||
Any other information the entity wishes to provide about the +securities to be quoted | ||||
ASX +security code and description | ||||
LCTO : OPTION EXPIRING 19-APR-2024 DEFERRED | ||||
For | Issue date | |||
30/12/2021 | ||||
Application for quotation of +securities | 4 / 6 |
Application for quotation of +securities
Issue details
Number of +securities to be quoted
15,052,678
For personal use only
Issue currency | Issue price or consideration per +security |
AUD - Australian Dollar | AUD 0.00000000 |
Any other information the entity wishes to provide about the +securities to be quoted
Application for quotation of +securities | 5 / 6 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Living Cell Technologies Limited published this content on 29 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 December 2021 05:36:03 UTC.